156 related articles for article (PubMed ID: 20638089)
21. Pharmacokinetics of tulathromycin following administration to stocker cattle with remote delivery devices.
Rivera JD; Woolums AR; Giguère S; Johnson JT; Lutz AG; Tipton PN; Crosby WB; Hice I; Thoresen M
J Anim Sci; 2019 Nov; 97(11):4482-4487. PubMed ID: 31583406
[TBL] [Abstract][Full Text] [Related]
22. A single laboratory-validated LC-MS method for the analysis of tulathromycin residues in bison and deer sera and selected tissues of white-tailed deer.
Boison JO; Bachtold K; Matus J; Alcorn J; Woodbury M
Drug Test Anal; 2016 May; 8(5-6):584-95. PubMed ID: 27443215
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic efficacy of tulathromycin, a novel triamilide antimicrobial, against bovine respiratory disease in feeder calves.
Kilgore WR; Spensley MS; Sun F; Nutsch RG; Rooney KA; Skogerboe TL
Vet Ther; 2005; 6(2):143-53. PubMed ID: 16094562
[TBL] [Abstract][Full Text] [Related]
24. Population pharmacokinetics of a single intramuscular administration of tulathromycin in adult desert tortoises (Gopherus agassizii).
Kinney ME; Lamberski N; Wack R; Foster R; Neely M; Tell L; Gehring R
J Vet Pharmacol Ther; 2014 Oct; 37(5):500-7. PubMed ID: 24611596
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary pharmacokinetics of tulathromycin in swine. Part I: Lung homogenate in healthy pigs and pigs challenged intratracheally with lipopolysaccharide of Escherichia coli.
Villarino N; Lesman S; Fielder A; García-Tapia D; Cox S; Lucas M; Robinson J; Brown SA; Martín-Jiménez T
J Vet Pharmacol Ther; 2013 Aug; 36(4):329-39. PubMed ID: 23072251
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and milk penetration of moxifloxacin after intravenous and subcutaneous administration to lactating goats.
Fernández-Varón E; Villamayor L; Escudero E; Espuny A; Cárceles CM
Vet J; 2006 Sep; 172(2):302-7. PubMed ID: 15908243
[TBL] [Abstract][Full Text] [Related]
27. Synovial fluid pharmacokinetics of tulathromycin, gamithromycin and florfenicol after a single subcutaneous dose in cattle.
Jones ML; Washburn KE; Fajt VR; Rice S; Coetzee JF
BMC Vet Res; 2015 Feb; 11():26. PubMed ID: 25886555
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of tulathromycin in healthy and neutropenic mice challenged intranasally with lipopolysaccharide from Escherichia coli.
Villarino N; Brown SA; Martín-Jiménez T
Antimicrob Agents Chemother; 2012 Aug; 56(8):4078-86. PubMed ID: 22585224
[TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy of tulathromycin, tilmicosin, and florfenicol in the treatment of bovine respiratory disease in stocker cattle.
Nutsch RG; Skogerboe TL; Rooney KA; Weigel DJ; Gajewski K; Lechtenberg KF
Vet Ther; 2005; 6(2):167-79. PubMed ID: 16094564
[TBL] [Abstract][Full Text] [Related]
30. The influence of Actinobacillus pleuropneumoniae infection on tulathromycin pharmacokinetics and lung tissue disposition in pigs.
Gajda A; Bladek T; Jablonski A; Posyniak A
J Vet Pharmacol Ther; 2016 Apr; 39(2):176-82. PubMed ID: 26270490
[TBL] [Abstract][Full Text] [Related]
31. Clinical effectiveness of tulathromycin, a novel triamilide antimicrobial, for the control of respiratory disease in cattle at high risk for developing bovine respiratory disease.
Kilgore WR; Spensley MS; Sun F; Nutsch RG; Rooney KA; Skogerboe TL
Vet Ther; 2005; 6(2):136-42. PubMed ID: 16094561
[TBL] [Abstract][Full Text] [Related]
32. Tulathromycin: an overview of a new triamilide antibiotic for livestock respiratory disease.
Evans NA
Vet Ther; 2005; 6(2):83-95. PubMed ID: 16094557
[TBL] [Abstract][Full Text] [Related]
33. Standard PK/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf.
Toutain PL; Potter T; Pelligand L; Lacroix M; Illambas J; Lees P
J Vet Pharmacol Ther; 2017 Jan; 40(1):16-27. PubMed ID: 27501187
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of ceftiofur crystalline free acid after single subcutaneous administration in lactating and nonlactating domestic goats (Capra aegagrus hircus).
Doré E; Angelos JA; Rowe JD; Carlson JL; Wetzlich SE; Kieu HT; Tell LA
J Vet Pharmacol Ther; 2011 Feb; 34(1):25-30. PubMed ID: 21219340
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of tulathromycin in the treatment and prevention of natural outbreaks of bovine respiratory disease in European cattle.
Godinho KS; Wolf RM; Sherington J; Rowan TG; Sunderland SJ; Evans NA
Vet Ther; 2005; 6(2):122-35. PubMed ID: 16094560
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic/pharmacodynamic (PK/PD) evaluation of tulathromycin against Haemophilus parasuis in an experimental neutropenic guinea pig model.
Zhao Y; Guo LL; Fang B; Liu B
PLoS One; 2018; 13(12):e0209177. PubMed ID: 30596709
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of tulathromycin or enrofloxacin for initial treatment of naturally occurring bovine respiratory disease in feeder calves.
Robb EJ; Tucker CM; Corley L; Bryson WL; Rogers KC; Sturgess K; Bade DJ; Brodersen B
Vet Ther; 2007; 8(2):127-35. PubMed ID: 17616947
[TBL] [Abstract][Full Text] [Related]
38. Comparative pharmacokinetics of amikacin following a single intramuscular or subcutaneous administration in goats (Capra hircus).
Uppal RP; Verma SP; Verma V; Garg SK
Vet Res; 1997; 28(6):565-70. PubMed ID: 9428150
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of tulathromycin in edible tissues of healthy and experimentally infected pigs with Actinobacillus pleuropneumoniae.
Bladek T; Posyniak A; Jablonski A; Gajda A
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2015; 32(11):1823-32. PubMed ID: 26247868
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of tulathromycin in the treatment of bovine respiratory disease associated with induced Mycoplasma bovis infections in young dairy calves.
Godinho KS; Rae A; Windsor GD; Tilt N; Rowan TG; Sunderland SJ
Vet Ther; 2005; 6(2):96-112. PubMed ID: 16094558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
